NCT00404131View on ClinicalTrials.gov

Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions
Dry Eye Disease
Interventions
DRUG

diquafosol tetrasodium (INS365) Ophthalmic Solution

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00404131 - Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter